Shibin Zhou

Papers

Total Citations

792

H-Index

About

Shibin Zhou is a pioneering researcher in cancer biology and bacterial therapeutics, best known for engineering tumour-targeting bacteria to fight cancer. His landmark 2018 paper, "Tumour-targeting bacteria engineered to fight cancer," has garnered over 790 citations, highlighting its profound impact on the field. Zhou’s major contributions lie in developing genetically modified bacteria that selectively colonize and destroy tumours, offering a novel approach to cancer treatment that overcomes limitations of conventional therapies. His work integrates synthetic biology, microbiology, and oncology to create "living therapeutics" that can deliver drugs, modulate immune responses, or directly lyse cancer cells. Beyond this, Zhou has advanced our understanding of tumour microenvironment interactions and bacterial delivery systems. His research has been instrumental in translating preclinical concepts into clinical trials, with notable achievements including the design of attenuated Salmonella strains for targeted therapy. With a citation count exceeding 790 for his most cited work, Zhou’s innovative strategies continue to inspire new avenues in cancer immunotherapy and precision medicine, making him a key figure in the intersection of microbiology and oncology.